Vical’s gene-based interferon-omega gets US patent (PharmaBiz)
Vical’s gene-based interferon-omega gets US patent (PharmaBiz)
Vical Incorporated announced the issuance of US Patent No 7,470,675 covering the composition, delivery and use of gene-based interferon-omega. Interferon-omega is part of the interferon family of proteins which are naturally produced by the immune system.